Doctors & Drug Makers_World Health Organization & Drug Makers
No Free Lunch is an example of disingenuous focus on trivia while avoiding the real issues that are corrupting medicine.
Flu Vaccine–where is the evidence?
This is an addendum to yesterday's Infomail in which we disseminated disinformation issued by the U.S. Center for Disease Control (CDC). www.ahrp.org/cms/content/view/396/80
AHRP Comments on Smallpox Vaccine Testing on Children
THE ALIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) 142 West End Avenue, Suite 28P New York, NY 10023 www.ahrp.org FDA Docket Number 02N-0466 Comments re: Proposed smallpox vaccine trial to test the safety of Dryvax administration to children 2 to 5 years of age Recent public and professional debate about smallpox…
Bristol Myers Squibb Takes Serzone off the market on June 14 – AP
Bristol Myers Squibb Takes Serzone off the market on June 14 – AP Wed, 19 May 2004 The antidepressant Serzone, TAKEN OFF THE MARKET as of June 14 (for “business reasons” the company says). The drug was already taken off the market in Europe, Australia, New Zealand and Canada. In…
Article
Letter from David Healy, MD to Peter J. Pitts Executive Summary of suicidal evidence not addressed by FDA In the light of Traci Johnson’s death on February 7th 2004, will FDA obtain Pfizer’s entire folder on the 1982 Hindmarch study in which healthy volunteers were given Zoloft, and make a…
Int’l Registration of Clinical Research WHO
Int’l Registration of Clinical Research WHO Tue, 6 Apr 2004 On April 3, the World Health Organization (WHO) and Current Controlled Trials, Ltd (based in London, Philadelphia and Tokyo) announced that all randomized controlled clinical trials approved by the WHO ethics committee will be registered in a unique international registry…
Human Pesticide Experiment: The Slippery Slope – Sunday Herald
September 9, 2002 Human Pesticide Experiment: The Slippery Slope – Sunday Herald Note: more info. available on AHRP’s human pesticide experiment page. FYI Pesticide experiments are unethical because human beings are exposed to poisonous substances. Because there is absolutely no potential therapeutic purpose, such experiments violate the Nuremberg Code. The…
British Medical Journal: Something is rotten at the heart of FDA / Glaxo faces class action suit
British Medical Journal: Something is rotten at the heart of FDA / Glaxo faces class action suit Sun, 5 Dec 2004 “Something is rotten at the heart of the FDA.” That’s the opening of an editorial in the British Medical Journal. [1] Indeed, there is something rotten at the heart…
Israeli State Comptroller Blasts Researchers for Experimenting on Patients without Consent
Israeli State Comptroller Blasts Researchers for Experimenting on Patients without Consent Tue, 26 Jul 2005 Patients the world over need adeaquate protection from overreaching physicians who use patients to test experimental drugs and procedures without their informed consent. Jacques Michel, a retired director of Hadassah Hospital in Jerusalem who also…
Big Pharma’s Dirty Little Secret
Big Pharma’s Dirty Little Secret Mon, 27 Dec 2004 Dr. Peter Rost, Vice-President marketing, Pfizer, has taken a principled stand by speaking out against his industry’s “drity little secrets:” “Our dirty little secret is that the drug industry already sells its products, right here in the U.S., at the same…
SSRI Defects: Infants Suffer Drug Withdrawal / Adults risk GI bleeding
SSRI Defects: Infants Suffer Drug Withdrawal / Adults risk GI bleeding Wed, 18 May 2005 The Associated Press reports that new research confirms that: “Babies born to women taking antidepressants in the last three months of pregnancy were three times more likely to develop drug-related symptoms than those born to…
Take Action: Just Say No to Stigmatizing Screening and Unsafe Drugs
Take Action: Just Say No to Stigmatizing Screening and Unsafe Drugs Tue, 26 Oct 2004 FYI /ACTION! AHRP believes that America’s school children should not be screened and labeled without a guarantee of the proven accuracy of the screening tool, and the proven safety and therapeutic value of the treatment…